GA
TMCI icon

Gagnon Advisors’s Treace Medical Concepts TMCI Stock Holding History

Gagnon Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,534,034
Closed -$3.76M – 25
2025
Q4 		$3.76M Buy
1,534,034
+565,570
+58% +$2.46M 2.39% 18
2025
Q3 		$6.5M Buy
968,464
+138,194
+17% +$902K 4.01% 12
2025
Q2 		$4.88M Buy
830,270
+340,379
+69% +$2.22M 3.28% 15
2025
Q1 		$4.11M Hold
489,891
– – 2.9% 17
2024
Q4 		$3.64M Hold
489,891
– – 2.33% 19
2024
Q3 		$2.84M Buy
+489,891
New +$3.15M 1.84% 21

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gagnon Advisors's TMCI Position: Q1 2026 in Review

Gagnon Advisors sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 1,534,034 shares — an estimated $3.76M sold.

Gagnon Advisors first reported a position in TMCI in Q3 2024 and held it in 6 quarters. The position peaked at $6.5M in Q3 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Gagnon Advisors reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Gagnon Advisors sold 1,534,034 Treace Medical Concepts shares in Q1 2026, an estimated $3.76M.
  • Gagnon Advisors first reported a position in Treace Medical Concepts in Q3 2024 and held it in 6 quarters.
  • Gagnon Advisors's Treace Medical Concepts position peaked at $6.5M in Q3 2025.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Gagnon Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.